Basal  	Basal  	 FW	O
elevated  	elevated  	 FW	B-NP
serum  	serum  	 FW	I-NP
calcium  	calcium  	 FW	I-NP
phosphate  	phosphate  	 FW	I-NP
product  	product  	 NN	I-NP
as  	as  	 IN	O
an  	an  	 DT	O
independent  	independent  	 JJ	O
risk  	risk  	 NN	B-NP
factor  	factor  	 NN	I-NP
for  	for  	 IN	O
mortality  	mortality  	 NN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
fractures  	fractures  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
proximal  	proximal  	 JJ	O
femur-A  	femur-A  	 JJ	O
20  	20  	 CD	O
year  	year  	 NN	B-NP
observation  	observation  	 NN	I-NP
study  	study  	 NN	I-NP
Fractures  	Fractures  	 NNS	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
proximal  	proximal  	 JJ	I-NP
femur  	femur  	 NNS	I-NP
are  	are  	 VBP	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
cause  	cause  	 NN	O
of  	of  	 IN	O
mortality  	mortality  	 NN	O
and  	and  	 CC	O
morbidity  	morbidity  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
elderly  	elderly  	 JJ	O
population 	population 	 NN	O
.  	.  	 .	O
Yet  	Yet  	 RB	O
predictive  	predictive  	 JJ	B-NP
marker  	marker  	 NN	I-NP
of  	of  	 IN	O
unfavourable  	unfavourable  	 JJ	O
prognosis  	prognosis  	 NNS	O
are  	are  	 VBP	O
still  	still  	 RB	O
lacking 	lacking 	 VBG	O
.  	.  	 .	O
Calcium  	Calcium  	 JJ	B-NP
phosphate  	phosphate  	 JJ	I-NP
product  	product  	 NN	I-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
marker  	marker  	 NN	O
of  	of  	 IN	O
osteo-renal  	osteo-renal  	 JJ	B-NP
dysregulation 	dysregulation 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
study  	study  	 NN	O
investigated  	investigated  	 VBD	O
the  	the  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
serum  	serum  	 JJ	B-NP
calcium  	calcium  	 NN	I-NP
phosphate  	phosphate  	 NN	I-NP
product  	product  	 NN	I-NP
( 	( 	 -LRB-	O
SCPP 	SCPP 	 NNP	B-NP
)  	)  	 -RRB-	O
levels  	levels  	 NNS	O
as  	as  	 IN	O
a  	a  	 DT	O
prognostic  	prognostic  	 JJ	B-NP
parameter  	parameter  	 NN	I-NP
for  	for  	 IN	O
outcome  	outcome  	 NN	O
in  	in  	 IN	O
those  	those  	 DT	O
patients 	patients 	 NNS	O
.  	.  	 .	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
3577  	3577  	 CD	O
consecutive  	consecutive  	 JJ	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
diagnosed  	diagnosed  	 JJ	O
fractures  	fractures  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
proximal  	proximal  	 JJ	B-NP
femur  	femur  	 NN	I-NP
were  	were  	 VBD	O
included  	included  	 VBN	O
in  	in  	 IN	O
our  	our  	 PRP$	O
study  	study  	 NN	O
( 	( 	 -LRB-	O
72.5 	72.5 	 NNP	O
%  	%  	 NN	O
females 	females 	 NNS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
SCPP  	SCPP  	 NNP	B-NP
was  	was  	 VBD	O
divided  	divided  	 VBN	O
into  	into  	 IN	O
tertiles 	tertiles 	 NNS	B-NP
:  	:  	 :	O
< 	< 	 SYM	O
1.92mmol 	1.92mmol 	 CD	O
( 	( 	 -LRB-	O
2 	2 	 LS	O
) 	) 	 -RRB-	O
/ 	/ 	 FW	O
l 	l 	 FW	B-NP
( 	( 	 -LRB-	I-NP
2 	2 	 LS	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
1.93-2.38mmol 	1.93-2.38mmol 	 NNP	O
( 	( 	 -LRB-	O
2 	2 	 LS	O
) 	) 	 -RRB-	O
/ 	/ 	 FW	O
l 	l 	 FW	B-NP
( 	( 	 -LRB-	I-NP
2 	2 	 LS	I-NP
)  	)  	 -RRB-	I-NP
and  	and  	 CC	O
> 	> 	 NNP	O
2.39mmol 	2.39mmol 	 NNP	O
( 	( 	 -LRB-	O
2 	2 	 LS	O
) 	) 	 -RRB-	O
/ 	/ 	 FW	O
l 	l 	 FW	B-NP
( 	( 	 -LRB-	I-NP
2 	2 	 LS	I-NP
) 	) 	 -RRB-	I-NP
.  	.  	 .	O
Data  	Data  	 NNP	O
collection  	collection  	 NN	O
was  	was  	 VBD	O
performed  	performed  	 VBN	O
prospectively  	prospectively  	 RB	O
and  	and  	 CC	O
statistical  	statistical  	 JJ	B-NP
evaluation  	evaluation  	 NN	I-NP
was  	was  	 VBD	O
performed  	performed  	 VBN	O
retrospectively 	retrospectively 	 NN	O
.  	.  	 .	O
Mean  	Mean  	 VB	O
follow  	follow  	 VB	O
up  	up  	 RP	O
in  	in  	 IN	O
our  	our  	 PRP$	O
study  	study  	 NN	B-NP
group  	group  	 NN	I-NP
was  	was  	 VBD	O
11.0±0.3  	11.0±0.3  	 CD	O
months 	months 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
mean  	mean  	 JJ	O
age  	age  	 NN	O
of  	of  	 IN	O
our  	our  	 PRP$	O
study  	study  	 NN	B-NP
group  	group  	 NN	I-NP
was  	was  	 VBD	O
79.0  	79.0  	 CD	O
years  	years  	 NNS	O
( 	( 	 -LRB-	O
SEM  	SEM  	 NNP	B-NP
±14  	±14  	 NNP	O
years 	years 	 NNS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
To  	To  	 TO	O
facilitate  	facilitate  	 VB	O
analysis 	analysis 	 NN	O
,  	,  	 ,	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
divided  	divided  	 VBN	O
in  	in  	 IN	O
two  	two  	 CD	O
groups 	groups 	 NNS	O
:  	:  	 :	O
≤84  	≤84  	 CD	O
years  	years  	 NNS	O
( 	( 	 -LRB-	O
64.4 	64.4 	 NNP	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
≥85  	≥85  	 CD	O
years  	years  	 NNS	O
( 	( 	 -LRB-	O
35.6 	35.6 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
mortality  	mortality  	 NN	O
< 	< 	 SYM	O
12  	12  	 CD	O
months  	months  	 NNS	O
was  	was  	 VBD	O
12.4 	12.4 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
n=445 	n=445 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
our  	our  	 PRP$	O
study  	study  	 NN	B-NP
population  	population  	 NN	I-NP
higher  	higher  	 RBR	O
SCPP  	SCPP  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
ad  	ad  	 NN	I-NP
admission  	admission  	 NN	I-NP
were  	were  	 VBD	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
markedly  	markedly  	 JJ	O
elevated  	elevated  	 JJ	O
mortality 	mortality 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
a  	a  	 DT	O
multivariate  	multivariate  	 JJ	B-NP
logistic  	logistic  	 JJ	I-NP
regression  	regression  	 JJ	I-NP
model  	model  	 NN	I-NP
adjusted  	adjusted  	 VBN	O
for  	for  	 IN	O
age  	age  	 NN	O
and  	and  	 CC	O
sex 	sex 	 NN	O
,  	,  	 ,	O
plasma  	plasma  	 JJ	B-NP
creatinine  	creatinine  	 NN	I-NP
and  	and  	 CC	O
haemoglobin  	haemoglobin  	 NN	B-NP
at  	at  	 IN	O
admission  	admission  	 NN	B-NP
caused  	caused  	 VBD	O
a  	a  	 DT	O
1.3  	1.3  	 CD	O
( 	( 	 -LRB-	O
CI 	CI 	 NNP	O
:  	:  	 :	O
1.01-1.6 	1.01-1.6 	 CD	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
SCPP  	SCPP  	 NNP	B-NP
1.93-2.38mmol 	1.93-2.38mmol 	 NNP	O
( 	( 	 -LRB-	O
2 	2 	 LS	O
) 	) 	 -RRB-	O
/ 	/ 	 FW	O
l 	l 	 FW	B-NP
( 	( 	 -LRB-	I-NP
2 	2 	 LS	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
1.6  	1.6  	 CD	O
( 	( 	 -LRB-	O
CI 	CI 	 NNP	O
:  	:  	 :	O
1.2-2.0 	1.2-2.0 	 CD	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
SPP  	SPP  	 NNP	B-NP
> 	> 	 NNP	O
2.39mmol 	2.39mmol 	 NNP	O
( 	( 	 -LRB-	O
2 	2 	 LS	O
) 	) 	 -RRB-	O
/ 	/ 	 FW	O
l 	l 	 FW	B-NP
( 	( 	 -LRB-	I-NP
2 	2 	 LS	I-NP
)  	)  	 -RRB-	I-NP
fold  	fold  	 JJ	I-NP
increase  	increase  	 NN	I-NP
in  	in  	 IN	O
overall  	overall  	 JJ	O
mortality  	mortality  	 NN	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
baseline  	baseline  	 JJ	B-NP
SCPP  	SCPP  	 NN	I-NP
levels  	levels  	 NNS	I-NP
(  	(  	 -LRB-	O
< 	< 	 SYM	O
1.92mmol 	1.92mmol 	 NNP	O
( 	( 	 -LRB-	O
2 	2 	 LS	O
) 	) 	 -RRB-	O
/ 	/ 	 FW	O
l 	l 	 FW	B-NP
( 	( 	 -LRB-	I-NP
2 	2 	 LS	I-NP
) 	) 	 -RRB-	I-NP
)  	)  	 -RRB-	O
as  	as  	 IN	O
reference  	reference  	 NN	B-NP
category 	category 	 NN	I-NP
.  	.  	 .	O
Those  	Those  	 DT	O
findings  	findings  	 NNS	O
in  	in  	 IN	O
our  	our  	 PRP$	O
study  	study  	 NN	B-NP
population  	population  	 NN	I-NP
with  	with  	 IN	O
3577  	3577  	 CD	O
patients  	patients  	 NNS	O
over  	over  	 IN	O
a  	a  	 DT	O
period  	period  	 NN	O
of  	of  	 IN	O
20  	20  	 CD	O
years  	years  	 NNS	O
proved  	proved  	 VBD	O
to  	to  	 TO	O
be 	be 	 VB	O
,  	,  	 ,	O
that  	that  	 WDT	O
serum  	serum  	 VBZ	B-NP
Ca  	Ca  	 JJ	I-NP
levels  	levels  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
a  	a  	 DT	O
good  	good  	 JJ	O
predictor  	predictor  	 NN	O
for  	for  	 IN	O
mortality  	mortality  	 NN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
fracture  	fracture  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
proximal  	proximal  	 JJ	I-NP
femur 	femur 	 NN	I-NP
.  	.  	 .	O
Further  	Further  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
are  	are  	 VBP	O
required  	required  	 VBN	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
whether  	whether  	 IN	O
these  	these  	 DT	O
high  	high  	 JJ	O
risk  	risk  	 NN	B-NP
patients  	patients  	 NNS	I-NP
might  	might  	 MD	O
benefit  	benefit  	 VB	O
from  	from  	 IN	O
specific  	specific  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
measurements 	measurements 	 NNS	I-NP
.  	.  	 .	O
This  	This  	 DT	O
prognostic  	prognostic  	 JJ	B-NP
factor  	factor  	 NN	I-NP
may  	may  	 MD	O
help  	help  	 VB	O
to  	to  	 TO	O
increase  	increase  	 VB	O
the  	the  	 DT	O
outcome  	outcome  	 NN	O
of  	of  	 IN	O
elderly  	elderly  	 JJ	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
a  	a  	 DT	O
fracture  	fracture  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
proximal  	proximal  	 JJ	I-NP
femur 	femur 	 NN	I-NP
.  	.  	 .	O
